Utilization of Metabolomics to Identify Serum Biomarkers for Hepatocellular Carcinoma in Patients with Liver Cirrhosis

Characterizing the metabolic changes pertaining to hepatocellular carcinoma (HCC) in patients with liver cirrhosis is believed to contribute towards early detection, treatment, and understanding of the molecular mechanisms of HCC. In this study, we compare metabolite levels in sera of 78 HCC cases w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ressom, Habtom W., Xiao, Jun Feng, Tuli, Leepika, Varghese, Rency S., Zhou, Bin, Tsai, Tsung-Heng, Nezami Ranjbar, Mohammad R., Zhao, Yi, Wang, Jinlian, Di Poto, Cristina, Cheema, Amrita K., Tadesse, Mahlet G., Goldman, Radoslav, Shetty, Kirti
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3419576/
https://ncbi.nlm.nih.gov/pubmed/22882828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.aca.2012.07.013
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia